Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: Impact on sorafenib cytotoxicity

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Rigalli, Juan Pablo ^a   Ciriaci, Nadia ^a   Arias, Agostina ^a   Ceballos, María Paula ^a   Villanueva, Silvina Stella Maris ^a   Luquita, Marcelo Gabriel ^a   Mottino, Aldo Domingo ^a   Ghanem, Carolina Inés ^b   Catania, Viviana Alicia ^a   Ruiz, María Laura ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Instituto de Investigaciones Farmacologicas   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; GENISTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN; ANTINEOPLASTIC AGENT; CARBANILAMIDE DERIVATIVE; CARRIER PROTEIN; MICRORNA; MIRN379 MICRORNA, HUMAN; NICOTINAMIDE; PHYTOESTROGEN; SORAFENIB;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; ANALOGS AND DERIVATIVES; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

GLYCINE MAX;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; LIVER NEOPLASMS; MEMBRANE TRANSPORT PROTEINS; MICRORNAS; NIACINAMIDE; PHENYLUREA COMPOUNDS; PHYTOESTROGENS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84924940483     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119502     Document Type: Article

References (56)

1. Anwar SL, Lehmann U. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. World J Gastroenterol. 2014; 20: 7894-7913. doi: 10.3748/wjg.v20.i24.7894 PMID: 24976726
2. Peck-Radosavljevic M. Drug therapy for advanced-stage liver cancer. Liver Cancer. 2014; 3: 125-131. doi: 10.1159/000343868 PMID: 24945003
3. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379: 1245-1255. doi: 10.1016/S0140-6736(11)61347-0 PMID: 22353262
4. Iyer R, Fetterly G, Lugade A, Thanavala Y. Sorafenib: a clinical and pharmacologic review. Expert Opin Pharmacother. 2010; 11: 1943-1955. doi: 10.1517/14656566.2010.496453 PMID: 20586710
5. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359: 378-390. doi: 10.1056/NEJMoa0708857 PMID: 18650514
6. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009; 10: 25-34. doi: 10.1016/S1470-2045(08)70285-7 PMID: 19095497
7. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev. 2003; 55: 3-29. PMID: 12535572
8. Borst P, Zelcer N, van de Wetering K. MRP2 and 3 in health and disease. Cancer Lett. 2006; 234: 51-61. PMID: 16387425
9. Nies AT, Keppler D. The apical conjugate efflux pump ABCC2 (MRP2) Pflugers Arch. 2007; 453: 643-659. PMID: 16847695
10. Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev. 2010; 62: 1-96. doi: 10.1124/pr.109.002014 PMID: 20103563
11. Sun L, Chen W, Qu L, Wu J, Si J. Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P-glycoprotein expression. Mol Med Rep. 2013; 8: 1883-1887. doi: 10.3892/mmr.2013.1742 PMID: 24145579
12. Yang T, Zheng ZM, Li XN, Li ZF, Wang Y, Bai L, et al. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells. Exp Biol Med (Maywood). 2013; 238: 1024-1032. doi: 10.1177/1535370213497321 PMID: 23925649
13. Korita PV, Wakai T, Shirai Y, Matsuda Y, Sakata J, Takamura M, et al. Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma. Oncol Rep. 2010; 23: 965-972. PMID: 20204280
14. Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ, et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A. 1999; 96: 6914-6919. PMID: 10359813
15. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A. 1998; 95: 15665-15670. PMID: 9861027
16. Herzog M, Storch CH, Gut P, Kotlyar D, Füllekrug J, Ehehalt R, et al. Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity. Naunyn Schmiedebergs Arch Pharmacol. 2011; 383: 1-11. doi: 10.1007/s00210-010-0568-8 PMID: 20936466
17. Li H, Zhou S, Li T, Liu Z, Wu J, Zeng G, et al. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference. Hepatogastroenterology. 2012; 59: 2238-2242. doi: 10.5754/hge11781 PMID: 23435138
18. Lagas JS, van Waterschoot RA, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH. Breast cancer resistance protein and P-glycoprotein limit sorafenib brain accumulation. Mol Cancer Ther. 2010; 9: 319-326. doi: 10.1158/1535-7163.MCT-09-0663 PMID: 20103600
19. Shibayama Y, Nakano K, Maeda H, Taguchi M, Ikeda R, Sugawara M, et al. Multidrug resistance protein 2 implicates anticancer drug-resistance to sorafenib. Biol Pharm Bull. 2011; 34: 433-435. PMID: 21372398
20. Ghassabian S, Rawling T, Zhou F, Doddareddy MR, Tattam BN, Hibbs DE, et al. Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites. Biochem Pharmacol. 2012; 84: 215-223. doi: 10.1016/j.bcp.2012.04.001 PMID: 22513143
21. Cui PH, Rawling T, Gillani TB, Bourget K, Wang XS, Zhou F, et al. Anti-proliferative actions of N′-desmethylsorafenib in human breast cancer cells. Biochem Pharmacol. 2013; 86: 419-427. doi: 10.1016/j.bcp.2013.05.014 PMID: 23732299
22. Köhle C, Bock KW. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem Pharmacol. 2009; 77: 689-699. doi: 10.1016/j.bcp.2008.05.020 PMID: 18606396
23. Li L, Stanton JD, Tolson AH, Luo Y, Wang H. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res. 2009; 26: 872-882. doi: 10.1007/s11095-008-9788-8 PMID: 19034627
24. Vore M, Zhao T, Zhang Y, Yan B, Thompson S. Insulin growth factor 2 mRNA binding protein 1 (IGF2BP1) regulates translation of the multidrug resistance protein 2 (MRP2) by binding to its 5′-untranslated region (5′UTR). FASEB J. 2011; 25: 1015.8.
25. Geick A, Eichelbaum M, Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem. 2001; 276: 14581-14587. PMID: 11297522
26. Haenisch S, Laechelt S, Bruckmueller H, Werk A, Noack A, Bruhn O, et al. Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379. Mol Pharmacol. 2011; 80: 314-320. doi: 10.1124/mol.110.070714 PMID: 21540293
27. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 2002; 3: 364-373. PMID: 12107024
28. Floyd KA, Stella DR, Wang CC, Laurentz S, McCabe GP, Srivastava OP, et al. Genistein and genistein-containing dietary supplements accelerate the early stages of cataractogenesis in the male ICR/f rat. Exp Eye Res. 2011; 92: 120-127. doi: 10.1016/j.exer.2010.12.006 PMID: 21147102
29. Barone M, Lofano K, De Tullio N, Licinio R, Albano F, Di Leo A. Dietary, endocrine, and metabolic factors in the development of colorectal cancer. J Gastrointest Cancer. 2012; 43: 13-19. doi: 10.1007/s12029-011-9332-7 PMID: 22045273
30. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr. 1995; 125: 777S-783S. PMID: 7884564
31. Salleh N, Helmy MM, Fadila KN, Yeong SO. Isoflavone genistein induces fluid secretion and morphological changes in the uteri of post-pubertal rats. Int J Med Sci. 2013; 10: 665-675. doi: 10.7150/ijms.5207 PMID: 23569430
32. Cao Y, Calafat A, Doerge D, Umbach D, Bernbaum J, Twaddle NC, et al. Isoflavones in urine, saliva and blood of infants - data from a pilot study on the estrogenic activity of soy formula. J Expo Sci Environ Epidemiol. 2009; 19: 223-234. doi: 10.1038/jes.2008.44 PMID: 18665197
33. Hishida M, Nomoto S, Inokawa Y, Hayashi M, Kanda M, Okamura Y, et al. Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis. Int J Oncol. 2014; 43: 88-94.
34. Tu CC, Kumar VB, Day CH, Kuo WW, Yeh SP, Chen RJ, et al. Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins. J Mol Endocrinol. 2013; 51: 203-212. doi: 10.1530/JME-13-0085 PMID: 23733894
35. Ruiz ML, Rigalli JP, Arias A, Villanueva SS, Banchio C, Vore M, et al. Estrogen receptor-α mediates human multidrug resistance associated protein 3 induction by 17 α-ethynylestradiol. Role of activator protein-1. Biochem Pharmacol. 2013; 86: 401-409. doi: 10.1016/j.bcp.2013.05.025 PMID: 23747343
36. Sormunen R, Eskelinen S, Lehto VP. Bile canaliculus formation in cultured HepG2 cells. Lab Invest. 1993; 68: 652-662. PMID: 8390592
37. Rigalli JP, Ruiz ML, Perdomo VG, Villanueva SS, Mottino AD, Catania VA. Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells. Toxicology. 2011; 285: 18-24. doi: 10.1016/j.tox.2011.03.015 PMID: 21459122
38. Martins R, Proenc¸a D, Silva B, Barbosa C, Silva AL, Faustino P, et al. Alternative polyadenylation and nonsense-mediated decay coordinately regulate the human HFE mRNA levels. PLoS One. 2012; 7: e35461. doi: 10.1371/journal.pone.0035461 PMID: 22530027
39. Kubitz R, Helmer A, Häussinger D. Biliary transport systems: short-term regulation. Methods Enzymol. 2005; 400: 542-557. PMID: 16399369
40. Rigalli JP, Perdomo VG, Luquita MG, Villanueva SS, Arias A, Theile D, et al. Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane-x-receptor. PLoS Negl Trop Dis. 2012; 6: e1951. doi: 10.1371/journal.pntd.0001951 PMID: 23272261
41. Weiss J, Dormann SM, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, Haefeli WE. Inhibition of P-glycoprotein by newer antidepressants. J Pharmacol Exp Ther. 2003; 305: 197-204. PMID: 12649369
42. Ye L, Yang X, Yang Z, Gao S, Yin T, Liu W, et al. The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells. Toxicol. Lett. 2013; 216: 86-99. doi: 10.1016/j.toxlet.2012.11.011 PMID: 23200901
43. Keubler A, Weiss J, Haefeli WE, Mikus G, Burhenne J. Drug interaction of efavirenz and midazolam: efavirenz activates the CYP3A-mediated midazolam 1′-hydroxylation in vitro. Drug Metab Dispos. 2012; 40: 178-182. doi: 10.1124/dmd.111.042879 PMID: 22019630
44. Van Rooij E. The art of microRNA research. Circ Res. 2011; 108: 219-234. doi: 10.1161/CIRCRESAHA.110.227496 PMID: 21252150
45. Roma MG, Crocenzi FA, Mottino AD. Dynamic localization of hepatocellular transporters in health and disease. World J Gastroenterol. 2008; 14: 6786-6801. PMID: 19058304
46. Ma J, Cheng L, Liu H, Zhang J, Shi Y, Zeng F, et al. Genistein down-regulates miR-223 expression in pancreatic cancer cells. Curr Drug Targets. 2013; 14: 1150-1156. PMID: 23834147
47. Li Y, Ross-Viola JS, Shay NF, Moore DD, Ricketts ML. Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner. J Nutr. 2009; 139: 898-904. doi: 10.3945/jn.108.103572 PMID: 19297428
48. Zhang T, Wang F, Xu HX, Yi L, Qin Y, Chang H, et al. Activation of nuclear factor erythroid 2-related factor 2 and PPARγ plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury. Br J Nutr. 2013; 109: 223-235. doi: 10.1017/S0007114512001110 PMID: 22716961
49. Arias A, Rigalli JP, Villanueva SS, Ruiz ML, Luquita MG, Perdomo VG, et al. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity. Toxicology. 2014; 320: 46-55. doi: 10.1016/j.tox.2014.03.007 PMID: 24685904
50. Manov I, Bashenko Y, Eliaz-Wolkowicz A, Mizrahi M, Liran O, Iancu TC. High-dose acetaminophen inhibits the lethal effect of doxorubicin in HepG2 cells: the role of P-glycoprotein and mitogen-activated protein kinase p44/p42 pathway. J Pharmacol Exp Ther. 2007; 332: 1013-1022.
51. Wang H, Zhai Z, Li N, Jin H, Chen J, Yuan S, et al. Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma. Phytomedicine. 2013; 20: 985-991. doi: 10.1016/j.phymed.2013.04.014 PMID: 23786867
52. Folmer Y, Schneider M, Blum HE, Hafkemeyer P. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs. Cancer Gene Ther. 2007; 14: 875-884. PMID: 17704753
53. Achira M, Suzuki H, Ito K, Sugiyama Y. Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4. AAPS PharmSci. 1999; 1: E18. PMID: 11741214
54. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res. 1982; 42: 3858-3863. PMID: 6286115
55. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther. 2008; 7: 2152-2159. doi: 10.1158/1535-7163.MCT-08-0021 PMID: 18645025
56. Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012; 6: 590-610. doi: 10.1016/j.molonc.2012.09.006 PMID: 23102669